Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Does high C-reactive protein concentration increase atherosclerosis? The Whitehall II Study.

Kivimäki M, Lawlor DA, Smith GD, Kumari M, Donald A, Britton A, Casas JP, Shah T, Brunner E, Timpson NJ, Halcox JP, Miller MA, Humphries SE, Deanfield J, Marmot MG, Hingorani AD.

PLoS One. 2008 Aug 20;3(8):e3013. doi: 10.1371/journal.pone.0003013.

2.

Inflammation, insulin resistance, and diabetes--Mendelian randomization using CRP haplotypes points upstream.

Brunner EJ, Kivimäki M, Witte DR, Lawlor DA, Davey Smith G, Cooper JA, Miller M, Lowe GD, Rumley A, Casas JP, Shah T, Humphries SE, Hingorani AD, Marmot MG, Timpson NJ, Kumari M.

PLoS Med. 2008 Aug 12;5(8):e155. doi: 10.1371/journal.pmed.0050155.

3.

Polymorphism in the C-reactive protein (CRP) gene affects CRP levels in plasma and one early marker of atherosclerosis in men: The Health 2000 Survey.

Kettunen T, Eklund C, Kähönen M, Jula A, Päivä H, Lyytikäinen LP, Hurme M, Lehtimäki T.

Scand J Clin Lab Invest. 2011 Sep;71(5):353-61. doi: 10.3109/00365513.2011.568123. Epub 2011 Mar 17.

PMID:
21413847
4.

C-reactive protein as a marker of progression of carotid atherosclerosis in subjects with type 2 diabetes mellitus.

Pleskovič A, Letonja MŠ, Vujkovac AC, Nikolajević Starčević J, Gazdikova K, Caprnda M, Gaspar L, Kruzliak P, Petrovič D.

Vasa. 2017 May;46(3):187-192. doi: 10.1024/0301-1526/a000614. Epub 2017 Feb 20.

PMID:
28218562
5.

Polymorphisms of the CRP gene inhibit inflammatory response and increase susceptibility to depression: the Health in Men Study.

Almeida OP, Norman PE, Allcock R, van Bockxmeer F, Hankey GJ, Jamrozik K, Flicker L.

Int J Epidemiol. 2009 Aug;38(4):1049-59. doi: 10.1093/ije/dyp199. Epub 2009 May 11.

6.

Polymorphisms XbaI (rs693) and EcoRI (rs1042031) of the ApoB gene are associated with carotid plaques but not with carotid intima-media thickness in patients with diabetes mellitus type 2.

Nikolajevic Starcevic J, Santl Letonja M, Praznikar ZJ, Makuc J, Vujkovac AC, Petrovic D.

Vasa. 2014 May;43(3):171-80. doi: 10.1024/0301-1526/a000346.

PMID:
24797048
7.

The association of C-reactive protein and CRP genotype with coronary heart disease: findings from five studies with 4,610 cases amongst 18,637 participants.

Lawlor DA, Harbord RM, Timpson NJ, Lowe GD, Rumley A, Gaunt TR, Baker I, Yarnell JW, Kivimäki M, Kumari M, Norman PE, Jamrozik K, Hankey GJ, Almeida OP, Flicker L, Warrington N, Marmot MG, Ben-Shlomo Y, Palmer LJ, Day IN, Ebrahim S, Smith GD.

PLoS One. 2008 Aug 20;3(8):e3011. doi: 10.1371/journal.pone.0003011.

8.

Association of C-reactive protein with blood pressure and hypertension: life course confounding and mendelian randomization tests of causality.

Davey Smith G, Lawlor DA, Harbord R, Timpson N, Rumley A, Lowe GD, Day IN, Ebrahim S.

Arterioscler Thromb Vasc Biol. 2005 May;25(5):1051-6. Epub 2005 Feb 24. Erratum in: Arterioscler Thromb Vasc Biol. 2005 Aug;25(8):e129.

9.

Lifetime body mass index and later atherosclerosis risk in young adults: examining causal links using Mendelian randomization in the Cardiovascular Risk in Young Finns study.

Kivimäki M, Smith GD, Timpson NJ, Lawlor DA, Batty GD, Kähönen M, Juonala M, Rönnemaa T, Viikari JS, Lehtimäki T, Raitakari OT.

Eur Heart J. 2008 Oct;29(20):2552-60. doi: 10.1093/eurheartj/ehn252. Epub 2008 Jun 10.

10.

Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events.

Lange LA, Carlson CS, Hindorff LA, Lange EM, Walston J, Durda JP, Cushman M, Bis JC, Zeng D, Lin D, Kuller LH, Nickerson DA, Psaty BM, Tracy RP, Reiner AP.

JAMA. 2006 Dec 13;296(22):2703-11.

PMID:
17164456
11.

Investigating the Causal Relationship of C-Reactive Protein with 32 Complex Somatic and Psychiatric Outcomes: A Large-Scale Cross-Consortium Mendelian Randomization Study.

Prins BP, Abbasi A, Wong A, Vaez A, Nolte I, Franceschini N, Stuart PE, Guterriez Achury J, Mistry V, Bradfield JP, Valdes AM, Bras J, Shatunov A; PAGE Consortium; International Stroke Genetics Consortium; Systemic Sclerosis consortium; Treat OA consortium; DIAGRAM Consortium; CARDIoGRAMplusC4D Consortium; ALS consortium; International Parkinson’s Disease Genomics Consortium; Autism Spectrum Disorder Working Group of the Psychiatric Genomics Consortium; CKDGen consortium; GERAD1 Consortium; International Consortium for Blood Pressure; Schizophrenia Working Group of the Psychiatric Genomics Consortium; Inflammation Working Group of the CHARGE Consortium, Lu C, Han B, Raychaudhuri S, Bevan S, Mayes MD, Tsoi LC, Evangelou E, Nair RP, Grant SF, Polychronakos C, Radstake TR, van Heel DA, Dunstan ML, Wood NW, Al-Chalabi A, Dehghan A, Hakonarson H, Markus HS, Elder JT, Knight J, Arking DE, Spector TD, Koeleman BP, van Duijn CM, Martin J, Morris AP, Weersma RK, Wijmenga C, Munroe PB, Perry JR, Pouget JG, Jamshidi Y, Snieder H, Alizadeh BZ.

PLoS Med. 2016 Jun 21;13(6):e1001976. doi: 10.1371/journal.pmed.1001976. eCollection 2016 Jun.

12.

Association of the -757T>C polymorphism in the CRP gene with circulating C-reactive protein levels and carotid atherosclerosis.

Ben Assayag E, Shenhar-Tsarfaty S, Bova I, Berliner S, Usher S, Peretz H, Shapira I, Bornstein NM.

Thromb Res. 2009 Sep;124(4):458-62. doi: 10.1016/j.thromres.2009.04.008. Epub 2009 May 9.

PMID:
19428053
13.

On-treatment C-reactive protein and HDL cholesterol levels in patients at intermediate cardiovascular risk: impact on carotid intima-media thickness.

Pirro M, Vaudo G, Lupattelli G, Pasqualini L, Mannarino MR, Schillaci G, Alaeddin A, Paciullo F, Fallarino F, Bagaglia F, Mannarino E.

Life Sci. 2013 Sep 3;93(8):338-43. doi: 10.1016/j.lfs.2013.07.008. Epub 2013 Jul 19.

PMID:
23871987
14.

Associations between serum uric acid and markers of subclinical atherosclerosis in young adults. The cardiovascular risk in Young Finns study.

Oikonen M, Wendelin-Saarenhovi M, Lyytikäinen LP, Siitonen N, Loo BM, Jula A, Seppälä I, Saarikoski L, Lehtimäki T, Hutri-Kähönen N, Juonala M, Kähönen M, Huupponen R, Viikari JS, Raitakari OT.

Atherosclerosis. 2012 Aug;223(2):497-503. doi: 10.1016/j.atherosclerosis.2012.05.036. Epub 2012 Jun 7.

PMID:
22749515
15.
16.

Relationship between leptin and C-reactive protein in young Finnish adults.

Viikari LA, Huupponen RK, Viikari JS, Marniemi J, Eklund C, Hurme M, Lehtimäki T, Kivimäki M, Raitakari OT.

J Clin Endocrinol Metab. 2007 Dec;92(12):4753-8. Epub 2007 Sep 18.

PMID:
17878255
17.

Association of C-reactive protein with early-stage carotid atherosclerosis in Japanese patients with early-state type 2 diabetes mellitus.

Mita T, Watada H, Uchino H, Shimizu T, Hirose T, Tanaka Y, Kawamori R.

Endocr J. 2006 Oct;53(5):693-8. Epub 2006 Aug 23. Erratum in: Endocr J. 2010;57(4):357.

18.

The CRP genotype, serum levels and lung function in men: the Caerphilly Prospective Study.

Bolton CE, Schumacher W, Cockcroft JR, Timpson NJ, Smith GD, Gallacher J, Rumley A, Lowe GD, Ebrahim S, Shale DJ, Ben-Shlomo Y.

Clin Sci (Lond). 2011 Apr;120(8):347-55. doi: 10.1042/CS20100504.

PMID:
21080913
19.

CRP genotype and haplotype associations with serum C-reactive protein level and DAS28 in untreated early rheumatoid arthritis patients.

Ammitzbøll CG, Steffensen R, Bøgsted M, Hørslev-Petersen K, Hetland ML, Junker P, Johansen JS, Pødenphant J, Østergaard M, Ellingsen T, Stengaard-Pedersen K.

Arthritis Res Ther. 2014 Oct 31;16(5):475. doi: 10.1186/s13075-014-0475-3.

20.

Contribution of clinical correlates and 13 C-reactive protein gene polymorphisms to interindividual variability in serum C-reactive protein level.

Kathiresan S, Larson MG, Vasan RS, Guo CY, Gona P, Keaney JF Jr, Wilson PW, Newton-Cheh C, Musone SL, Camargo AL, Drake JA, Levy D, O'Donnell CJ, Hirschhorn JN, Benjamin EJ.

Circulation. 2006 Mar 21;113(11):1415-23. Epub 2006 Mar 13.

Supplemental Content

Support Center